deferoxamine has been researched along with Atypical Ductal Hyperplasia in 1 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Picardo, E | 1 |
| Mitidieri, M | 1 |
| Minniti, E | 1 |
| Ambroggio, S | 1 |
| D'Addato, F | 1 |
| Benedetto, C | 1 |
| Gregori, G | 1 |
| Baù, MG | 1 |
1 review available for deferoxamine and Atypical Ductal Hyperplasia
| Article | Year |
|---|---|
The first case of breast cancer in thalassemic patient: case report and review of literature.
Topics: Adult; beta-Thalassemia; Blood Transfusion; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltratin | 2015 |